Chair(s)
Prof. Ross Mckinnon, Chairman of the FIP Board of Pharmaceutical Sciences, Australia and Dr Rebecka Isaksson, FIP Scientific Secretary, UKIntroduction
This plenary session on innovative drug discovery and access will address current challenges, integrating industry-driven innovation with patient-centric clinical trials. A panel discussion titled, “Pharmacy’s role in bridging the gap,” will discuss new clinical trial models, innovative drug discoveries post-COVID-19 pandemic, and the role of pharmacists in improving access to groundbreaking medicines. It will showcase successful collaborations and recent breakthroughs in drug discovery.
Programme
16:30 – 16:45 |
SAHPRA support for health products innovation and development |
16:45 – 17:00 |
Alignment of drug discovery and development strategies with unmet medical need – are we there yet? |
17:00 – 17:15 |
Integration of research and innovation into policy and practice through the paradigm of a learning health system |
17:15 – 17:30 |
Panel discussion and Q&A |